Table 2.
RBBP8 promoter methylationb | ||||
---|---|---|---|---|
n a | low | high | p valuec | |
Parameter: | ||||
Gender | ||||
Male | 259 | 190 | 69 | 0.062 |
Female | 94 | 78 | 16 | |
Histological tumor grade | ||||
Low grade | 20 | 19 | 1 | 0.041 |
High grade | 330 | 247 | 83 | |
Tumor stage | ||||
pT1-pT2 | 109 | 86 | 23 | 0.49 |
pT3-pT4 | 216 | 163 | 53 | |
pN status | ||||
Negative | 212 | 161 | 51 | 0.866 |
Positive | 112 | 86 | 26 | |
pM status | ||||
Negative | 173 | 131 | 42 | 0.138 |
Positive | 7 | 7 | 0 | |
RBBP8 mRNAd | ||||
Low | 200 | 124 | 76 | ≤ 0.001 |
High | 200 | 175 | 25 |
Significant p values are in italics
aOnly patients with primary bladder cancer without any neoadjuvant therapy were included
bBased on TCGA 450K DNA methylation analysis
cFisher’s exact test
dRBBP8 mRNA expression was dichotomized at the median expression level